Clinical Trials & Studies
Accelerating Progress Against Cancer and Other Life-Threatening Diseases
Clinical trials and volunteer studies are a vital and critical component of disease research. Through these trials Fred Hutch researchers make new discoveries that lead to new ways to prevent, detect, diagnose or treat many diseases. Many of today's most effective treatments are based on the results of past trials and studies.
Looking For a COVID-19 Study?
Our researchers are conducting a number of therapeutic and non-therapuetic COVID-19 studies including treatment trials, observational studies and vaccine trials.
Clinical Trials
Each year, hundreds of trials are conducted by scientists at Fred Hutch, the University of Washington, and Seattle Children’s for a number of diseases. Patients enrolled on a clinical trial could benefit from the latest treatments available and will receive care through the Seattle Cancer Care Alliance (SCCA), our clinical care partner.
Volunteer Studies
Volunteer participation in clinical trials and observational studies is vital to disease research. No matter how promising a new drug, vaccine or procedure looks when tested in the laboratory or on animals, it cannot be approved for general use in humans until it has been carefully evaluated through several phases of clinical study that include volunteer participants. Observational studies are also crucial to determining cause and effect in human health, including how behavior, lifestyle, genetic factors and other traits may help prevent disease or contribute to disease risk. Some of our studies seek healthy participants for prevention research that may involve dietary changes, vitamin supplementation, increased physical activity or adoption of other health-promoting behaviors.
Fred Hutch Breast Density Study
Fred Hutch is conducting a research study to examine the impacts of body size, hormone levels, and the bacteria in the gut on breast density. If you are interested in this study, please take the screening survey.
ACE Study
The Acute Effects of Exercise on Breast Cancer Biomarkers (ACE Study) will test the effect of one 45-minute bout of moderate intensity exercise on cancer risk factors in healthy women.
Return to Work After Cancer Therapy
Fred Hutch Survivorship Program is recruiting young adult cancer survivors to a study to learn more about the impact of cancer therapy on employment and work-related quality of life.
HA-1 TCT-T Cell Study
Fred Hutch is recruiting patient with leukemia or related blood disorders who have relapsed after blood or marrow transplant to a phase 1 treatment study. Eligible participants may be offered a new type of cell therapy.
DVX201
This study is a Phase 1 study to determine the highest tolerated dose of an investigational cell therapy called DVX201 in patients hospitalized with COVID-19. DVX201 is an allogeneic NK (natural killer) cell therapy. NK cells are a normal part of your immune system that have the ability to identify and kill cells in the body that are infected by viruses such as COVID-19.
MK-4482-013
The primary objectives of the molnupiravir phase 3, multicenter, randomized, double-blind, placebo-controlled study are to determine the efficacy, and safety/tolerability, of molnupiravir (MK-4482) in adults who reside with a person infected with COVID-19.
Resolve RSLV-132
The purpose of this study is to assess the efficacy (decrease in severe fatigue), safety, and pharmacokinetics of RSLV-132 in subjects with post-acute COVID (long COVID) syndrome.
Immunity to Respiratory Illnesses
The Flu Study research team, in partnership with Fred Hutch, is looking for participants for a research study about immunity to respiratory illnesses like COVID-19 and influenza.
Dietary Intervention to Reduce Pain for Endometriosis
We are conducting a dietary intervention study which looks at the effects of a healthy diet on pain levels in people with endometriosis. We are looking for participants who may be assigned to either an intervention arm (healthy diet) or control arm (regular diet) for a 12-week period.
HIV Vaccine Studies
We are enrolling HIV-negative volunteers for a number of HIV vaccine studies. The products used in our trials are not produced from live HIV or from HIV-infected human cells and cannot cause HIV infection.
The Air Study
Fred Hutch is recruiting individuals to participate in a study to learn about how to reduce personal exposure to air pollution, a known risk factor for lung cancer. We hope to use the information that we gather to develop larger studies to increase knowledge and awareness of the harmful health effects of air pollution.
Malaria Studies
We are working to develop vaccines and medicines to prevent and limit malaria. To do this, we need healthy volunteers to take part in our clinical research studies. Read the general criteria and use our screening tool to see if you qualify for a study.
PALS
Prostate Cancer Active Lifestyle (PALS) is enrolling volunteers with low-grade prostate cancer who have chosen active surveillance of their disease. The goal is to learn whether weight loss through diet and exercise can slow the progression of prostate cancer.
Returning to School After Bone Marrow Transplant
Fred Hutch Survivorship Program is recruiting childhood transplant recipients, parents and caregivers to a study to lean more about what is easy or hard when returning to school after a transplant.
Faculty & Labs
Learn about the hundreds of faculty at Fred Hutch and their groundbreaking research — all of it aimed at eliminating cancer and related diseases as causes of human suffering and death.
Patient Treatment & Support
Patients have access to world-class cancer treatments developed at Fred Hutch through Seattle Cancer Care Alliance, which brings together research teams and cancer specialists from Fred Hutch, Seattle Children’s and UW Medicine.
Help Us Eliminate Cancer
Every dollar counts. Please support lifesaving research today.